Latest filing published 12 Sept 2025 for DURECT CORP. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Gail M. Farfel (board member) discloses dealings in 3 companies, chiefly Durect Corp, ProMIS Neurosciences Inc. and Zogenix, Inc. The record holds 10 filings, for trades running from 7 March 2022 to 11 September 2025.
Every open-market trade on record is a purchase: 6 purchases worth €31k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 1 share grant and 1 option exercise.
A typical purchase (the median) is worth €5,039. 3 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 12 September 2025, reports a transaction in Durect Corp. The last purchase on record was published on 16 December 2022, which is 1,402 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations